Download PDF
Thromb Haemost 1959; 03(02): 214-226
DOI: 10.1055/s-0038-1654383
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Thrombin Formation in Purified Systems

Douglas M Surgenor
1   Department of Biological Chemistry, Harvard Medical School and Protein Foundation, Boston, Mass., USA
,
Barbara B Steele
1   Department of Biological Chemistry, Harvard Medical School and Protein Foundation, Boston, Mass., USA
,
Donald F. H Wallach
1   Department of Biological Chemistry, Harvard Medical School and Protein Foundation, Boston, Mass., USA
› Author Affiliations
Further Information

Publication History

Publication Date:
08 June 2018 (online)

Also available at
   Permissions and Reprints

Summary

Study of the kinetic behavior of purified human clotting factors suggests that formation of prothrombin activator from platelets, plasma thromboplastin component (PTC), antihemophilic factor (AHF), Factor V and calcium proceeds by a sequence of reactions. The earliest detectable reaction is slow and involves platelets, PTC and calcium; an intermediate activated PTC is obtained which is free of platelet contamination and is characterized by its kinetic behavior. Platelets are also requisite at a later step in the sequence, possibly in an intermediate formed between activated PTC, AHF, platelets and calcium. Variations in platelets, AHF and PTC result in characteristic responses in the kinetics of thrombin formation.

 

  • References

  • 1 Bergsagel D. E. The Role of Calcium in the Activation of Christmas Factor. Brit. J. Haematol 1955; 7: 199
    PubMedGoogle Scholar
  • 2 Bergsagel D. E, Biggs R. The Christmas Factor. Rev. Hémat 1955; 10: 354
    PubMedGoogle Scholar
  • 3 Bergsagel D. E, Hougie C. Intermediate Stages in the Formation of Blood Thromboplastin. Brit. J. Haematol 1956; 2: 113
    CrossrefPubMedGoogle Scholar
  • 4 Biggs R, Douglas A. S, Macfarlane R. G. The Initial Stages of Blood Coagulation. J. Physiol. (Lond.) 1953; 122: 538
    CrossrefPubMedGoogle Scholar
  • 5 Nour Eldin F, Wilkinson J. F. The Isolation of Antihaemophilic Globulin from Brain Tissue. Brit. J. Haemat 1956; 2: 433
    CrossrefPubMedGoogle Scholar
  • 6 Surgenor D. M, Alexander B, Schmid K, Goldstein J. A system for the separation of the protein components of human plasma, II. The components of clotting mechanism. J. Phys. Coll. Chem 1951; 55: 94-101.
    PubMedGoogle Scholar
  • 7 Surgenor D. M, Steele B. B. Platelet-Antihemophilic Factor Interactions. Federation Proceedings 1958; 17: 1262
    PubMedGoogle Scholar
  • 8 Surgenor D. M, Walton K, Katz J. H, Steele B. B. In preparation
    PubMed
  • 9 Surgenor D. M, Wilson N. A. In preparation
    PubMed
  • 10 Tullis J. L. Preservation of Platelets. Amer. J. Med. Sci 1953; 226: 191
    CrossrefPubMedGoogle Scholar
  • 11 Tullis J. L, Surgenor D. M, Baudanza P. Preserved Platelets, Their Preparation, Storage and Clinical Use. Blood, in press
    PubMed
  • 12 Tullis J. L, Surgenor D. M, Tinch R. J, d’Hont M, Gilchrist F. L, Driscoll S, Batchelor W. H. The Principle of Closed System Cen-trifugation. Science 1956; 124: 792
    CrossrefPubMedGoogle Scholar
  • 13 Wallach D. F. H, Surgenor D. M, Steele B. B. Calcium-Lipid Complexes in Human Platelets. Blood 1958; 13: 589
    PubMedGoogle Scholar
  • 14 White S. G, Aggeler P. M, Glendening M. B. Plasma thromboplastin component (PTC), a hitherto unrecognized blood coagulation factor; case report of PTC deficiency. Blood 8: 101 1953;
    PubMedGoogle Scholar